Clinical Trial Update: Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study [NA]

View source ↗

Summary

The document indicates that the Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE study is currently recruiting for congenital heart disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease

Snippet

Sponsor: Starlight Cardiovascular Inc | Conditions: Congenital Heart Disease, Congenital Heart Disease (CHD) | NA | Status: RECRUITING